Indeks Rilis Pers English

Otis Appoints Nicolas Lopez President, Asia Pacific
PR Newswire
Senin, 2 Mar

Otis Appoints Nicolas Lopez President, Asia Pacific

Otis Appoints Nicolas Lopez President, Asia Pacific
PR Newswire
Senin, 2 Mar

Otis Appoints Nicolas Lopez President, Asia Pacific

Nopporn Suppipat divests all interest in Wind Energy Holding to Harbour
PR Newswire
Senin, 2 Mar

Nopporn Suppipat divests all interest in Wind Energy Holding to Harbour

SMU and Fudan Launch Region's First Tech-Focused DBA
PR Newswire
Senin, 2 Mar

SMU and Fudan Launch Region's First Tech-Focused DBA

Yonyou Unveils the Large Ontology Model (LOM): Forging a Deep-Thinking Digital Core for the Enterprise
PR Newswire
Senin, 2 Mar

Yonyou Unveils the Large Ontology Model (LOM): Forging a Deep-Thinking Digital Core for the Enterprise

Infobip is set to launch AgentOS to orchestrate autonomous AI-driven customer journeys at scale
PR Newswire
Senin, 2 Mar

Infobip is set to launch AgentOS to orchestrate autonomous AI-driven customer journeys at scale

Everyware Limited Launches Caterlord Checkout to Redefine Self-Service Payments for Restaurants in Hong Kong
PR Newswire
Senin, 2 Mar

Everyware Limited Launches Caterlord Checkout to Redefine Self-Service Payments for Restaurants in Hong Kong

SK Telecom CEO Unveils 'AI Native' Strategy at MWC26, Driving Korea's Leap in AI Innovation
PR Newswire
Senin, 2 Mar

SK Telecom CEO Unveils 'AI Native' Strategy at MWC26, Driving Korea's Leap in AI Innovation

XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication
PR Newswire
Senin, 2 Mar

XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication

Firmable Raises $14m Series A to Take AI-Native Sales Platform Global
PR Newswire
Senin, 2 Mar

Firmable Raises $14m Series A to Take AI-Native Sales Platform Global

Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
PR Newswire
Senin, 2 Mar

Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Understanding China's whole-process people's democracy
PR Newswire
Senin, 2 Mar

Understanding China's whole-process people's democracy

Toku Reports US$34.8 million Revenue in FY2025 as AI Adoption Gains Traction; Underlying Loss Improves
PR Newswire
Senin, 2 Mar

Toku Reports US$34.8 million Revenue in FY2025 as AI Adoption Gains Traction; Underlying Loss Improves

Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib in Moderate-to-Severe Atopic Dermatitis
PR Newswire
Senin, 2 Mar

Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib in Moderate-to-Severe Atopic Dermatitis

Investor Education Webinar
PR Newswire
Senin, 2 Mar

Investor Education Webinar

Trip.com's Go Explore Mega Sale Set to Launch - Save on Flights, Hotels, Tours & More
PR Newswire
Senin, 2 Mar

Trip.com's Go Explore Mega Sale Set to Launch - Save on Flights, Hotels, Tours & More

Say Hello to Speed: The Baseus PicoGo AM52 Qi2.2 Magnetic Power Bank Slim
PR Newswire
Minggu, 1 Mar

Say Hello to Speed: The Baseus PicoGo AM52 Qi2.2 Magnetic Power Bank Slim

Acwa Board of Directors names Dr. Samir J. Serhan Chief Executive Officer
PR Newswire
Minggu, 1 Mar

Acwa Board of Directors names Dr. Samir J. Serhan Chief Executive Officer

How China Drives Global Green Energy Transition through Intelligent Manufacturing
PR Newswire
Minggu, 1 Mar

How China Drives Global Green Energy Transition through Intelligent Manufacturing

Ericsson announces participation in the OCUDU Ecosystem Foundation to advance open, secure, and flexible network innovation
PR Newswire
Minggu, 1 Mar

Ericsson announces participation in the OCUDU Ecosystem Foundation to advance open, secure, and flexible network innovation